Skip to main content

Advertisement

Log in

Rheumatoid Vasculitis: A Diminishing Yet Devastating Menace

  • Vasculitis (L Espinoza, Section Editor)
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Rheumatoid vasculitis (RV) is an unusual complication of long-standing rheumatoid arthritis, which is characterized by the development of necrotizing or leukocytoclastic vasculitis involving small or medium-sized vessels. In this review, we aim to provide an update on the epidemiology, pathogenesis, clinical presentation, and management of this challenging extra-articular manifestation.

Recent Findings

RV is heterogenous in its clinical presentation depending on the organ and size of blood vessels involved. The most common organs involved are the skin and peripheral nerve. Based on recent population studies, the incidence has significantly decreased with early recognition and the advent of immunosuppressive drugs and biologics; however, the mortality rates remain high.

Summary

RV remains a serious extra-articular manifestation of RA that needs to be promptly recognized and treated. No consensus is available on treatment, given the ongoing debate of whether the biologics can trigger or treat RV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently have been highlighted as: • Of importance, •• Of major importance

  1. Bartels C, Bell C, Rosenthal A, et al. Decline in rheumatoid vasculitis prevalence among US veterans: a retrospective cross-sectional study. Arthritis Rheum. 2009;60(9):2553–7. doi:10.1002/art.24775.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Voskuyl AE, Zwinderman AH, Westedt ML, et al. Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis. 1996;55(2):190–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Bartels CM, Bridges AJ. Rheumatoid vasculitis: vanishing menace or target for new treatments? Curr Rheumatol Rep. 2010;12(6):414–9. doi:10.1007/s11926-010-0130-1.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Scott DG, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore). 1981;60(4):288–97.

    Article  CAS  Google Scholar 

  5. Flipo RM, Cardon T, Copin MD, et al. ICAM-1, E-selectin, and TNF alpha expression in labial salivary glands of patients with rheumatoid vasculitis. Ann Rheum Dis. 1997;56(1):41–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Martens PB, Goronzy JJ, Schaid D, et al. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum. 1997;40(6):1106–14.

    Article  CAS  PubMed  Google Scholar 

  7. Yen J, Moore B, Nakajima T, et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med. 2001;193(10):1159–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. •• Makol A, Crowson CS, Wetter DA, et al. Vasculitis associated with rheumatoid arthritis: a case-control study. Rheumatology (Oxford). 2014;53(5):890–9. doi:10.1093/rheumatology/ket475. This is a retrospective case-control study where 86 RV patients were compared to controls to identify risk factors for development of RV.

    Article  CAS  Google Scholar 

  9. Albano SA, Santana-Sahagun E, Weisman M. Cigarette smoking and rheumatoid arthritis. Semin Arthritis Rheum. 2001;31(3):146–59.

    Article  CAS  PubMed  Google Scholar 

  10. Gorman J, David-Vaudey E, Pai M, et al. Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. Arthritis Rheum. 2004;50(11):3476–84.

    Article  CAS  PubMed  Google Scholar 

  11. Turesson C, Schaid DJ, Weyand CM, et al. Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54(9):2776–83.

    Article  PubMed  Google Scholar 

  12. Watts RA, Scott DG. Vasculitis and inflammatory arthritis. Best Pract Res Clin Rheumatol. 2016;30(5):916–31. doi:10.1016/j.berh.2016.10.008.

    Article  PubMed  Google Scholar 

  13. •• Ntatsaki E, Mooney J, Scott DG, et al. Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy. Rheumatology (Oxford). 2014;53(1):145–52. doi:10.1093/rheumatology/ket326. In this study, the clinical manifestations of RV patients (2001–2010) were reviewed and compared to a previous cohort (1988–2000).

    Article  Google Scholar 

  14. Watts RA, Carruthers CA, Symmons DP. The incidence of rheumatoid vasculitis in the Norwich Health Authority. Br J Rheumatol. 1994;33(9):832–3.

    Article  CAS  PubMed  Google Scholar 

  15. Myasoedova E, Crowson CS, Turesson C, et al. Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study. J Rheumatol. 2011;38(6):983–9. doi:10.3899/jrheum.101133.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Genta MS, Genta RM, Gabay C. Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum. 2006;36(2):88–98.

    Article  PubMed  Google Scholar 

  17. Pagnoux C, Mahr A, Cohen P, et al. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore). 2005;84(2):115–28.

    Article  Google Scholar 

  18. van Laar JM, Smit VT, de Beus WM, et al. Rheumatoid vasculitis presenting as appendicitis. Clin Exp Rheumatol. 1998;16(6):736–8.

    PubMed  Google Scholar 

  19. Sandhu SK, Choy G. Vasculitis of the gallbladder in early rheumatoid arthritis. BMJ Case Rep. 2013; doi:10.1136/bcr-2012-008228.

  20. Souza AW, Rosa DP, Buosi AL, et al. Testicular vasculitis: a rare manifestation of rheumatoid arthritis. Rev Bras Reumatol. 2013;53(4):365–7.

    Article  PubMed  Google Scholar 

  21. Albada-Kuipers GA, Bruijn JA, Westedt ML, et al. Coronary arteritis complicating rheumatoid arthritis. Ann Rheum Dis. 1986;45(11):963–5.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Kaneko S, Yamashita H, Sugimori Y, et al. Rheumatoid arthritis-associated aortitis: a case report and literature review. Spring. 2014;3:509. doi:10.1186/2193-1801-3-509.

    Article  Google Scholar 

  23. Gravallese EM, Corson JM, Coblyn JS, et al. Rheumatoid aortitis: a rarely recognized but clinically significant entity. Medicine (Baltimore). 1989;68(2):95–106.

    Article  CAS  Google Scholar 

  24. Bannatayne GA. Rheumatoid arthritis, its pathology, morbid anatomy and treatment. 2nd ed. Bristol, England: John Wright; 1898. p. 182.

    Google Scholar 

  25. Watts RA, Mooney J, Lane SE, et al. Rheumatoid vasculitis: becoming extinct? Rheumatology (Oxford). 2004;43(7):920–3.

    Article  CAS  Google Scholar 

  26. Sharma A, Dhooria A, Aggarwal A, et al. Connective tissue disorder-associated vasculitis. Curr Rheumatol Rep. 2016;18(6):31. doi:10.1007/s11926-016-0584-x.

    Article  PubMed  Google Scholar 

  27. Scott DG, Bacon PA. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med. 1984;76(3):377–84.

    Article  CAS  PubMed  Google Scholar 

  28. Turesson C, Jacobsson LT. Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol. 2004;33(2):65–72.

    Article  CAS  PubMed  Google Scholar 

  29. Radic M, Martinovic Kaliterna D, Radic J. Overview of vasculitis and vasculopathy in rheumatoid arthritis—something to think about. Clin Rheumatol. 2013;32(7):937–42. doi:10.1007/s10067-013-2273-8.

    Article  PubMed  Google Scholar 

  30. Puéchal X, Said G, Hilliquin P, et al. Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum. 1995;38(11):1618–29.

    Article  PubMed  Google Scholar 

  31. Laskari K, Ahmadi-Simab K, Lamken M, et al. Are anti-cyclic citrullinated peptide autoantibodies seromarkers for rheumatoid vasculitis in a cohort of patients with systemic vasculitis? Ann Rheum Dis. 2010;69(2):469–71.

    Article  CAS  PubMed  Google Scholar 

  32. Coremans IE, Hagen EC, Daha MR, et al. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum. 1992;35(12):1466–75.

    Article  CAS  PubMed  Google Scholar 

  33. Magro CM, Crowson AN. The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients. J Cutan Pathol. 2003;30(1):1–10.

    Article  CAS  PubMed  Google Scholar 

  34. Sakaue S, Sumitomo S, Kubo K, et al. Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis. Rheumatology (Oxford). 2014;53(8):1529–30. doi:10.1093/rheumatology/keu008.

    Article  Google Scholar 

  35. Tanaka A, Hayaishi N, Kondo Y, et al. Severe gangrene accompanied by varicella zoster virus-related vasculitis mimicking rheumatoid vasculitis. Case Rep Dermatol. 2014;6(1):103–7. doi:10.1159/000360979.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Goldman JA, Casey HL, McIlwain H, et al. Limited plasmapheresis in rheumatoid arthritis with vasculitis. Arthritis Rheum. 1979;22(10):1146–50.

    Article  CAS  PubMed  Google Scholar 

  37. Puechal X, Miceli-Richard C, Mejjad O, et al. Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis. Ann Rheum Dis. 2008;67(6):880–4.

    Article  CAS  PubMed  Google Scholar 

  38. • Puechal X, Gottenberg JE, Berthelot JM, et al. Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: results from the AutoImmunity and Rituximab Registry. Arthritis Care Res (Hoboken). 2012;64(3):331–9. doi:10.1002/acr.20689. The authors assessed the outcome of RV patients treated with rituximab and found it to be a suitable therapeutic option to induce remission.

    Article  CAS  Google Scholar 

  39. Fujii W, Kohno M, Ishino H, et al. The rapid efficacy of abatacept in a patient with rheumatoid vasculitis. Mod Rheumatol. 2012;22(4):630–4. doi:10.1007/s10165-011-0559-8.

    Article  PubMed  Google Scholar 

  40. Iijima T, Suwabe T, Sumida K, et al. Tocilizumab improves systemic rheumatoid vasculitis with necrotizing crescentic glomerulonephritis. Mod Rheumatol. 2015;25(1):138–42. doi:10.3109/14397595.2013.874748.

    Article  PubMed  Google Scholar 

  41. Sumida K, Ubara Y, Takemoto F, et al. Successful treatment with humanized anti-interleukin 6 receptor antibody for multidrug-refractory and anti-tumour necrosis factor-resistant systemic rheumatoid vasculitis. Clin Exp Rheumatol. 2011;29(1 Suppl 64):S133.

    PubMed  Google Scholar 

  42. Watts RA, Carruthers DM, Scott DG. Isolated nailfold vasculitis in rheumatoid arthritis. Ann Rheum Dis. 1995;54(11):927–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. • Gutiérrez-González LA. Biological therapy-induced systemic vasculitis. Curr Rheumatol Rep. 2016;18(7):39. doi:10.1007/s11926-016-0588-6. This is an excellent review of vasculitis secondary to biologic therapy.

    Article  PubMed  Google Scholar 

  44. Makol A, Matteson EL, Warrington KJ. Rheumatoid vasculitis: an update. Curr Opin Rheumatol. 2015;27(1):63–70. doi:10.1097/BOR.0000000000000126.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shweta Kishore.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Vasculitis

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kishore, S., Maher, L. & Majithia, V. Rheumatoid Vasculitis: A Diminishing Yet Devastating Menace. Curr Rheumatol Rep 19, 39 (2017). https://doi.org/10.1007/s11926-017-0667-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11926-017-0667-3

Keywords

Navigation